Palatin Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PTN and buy or sell other stocks, ETFs, and their options commission-free!About PTN
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD).
CEOCarl Spana, PhD
CEOCarl Spana, PhD
Employees30
Employees30
HeadquartersCranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded1986
Founded1986
Employees30
Employees30
PTN Key Statistics
Market cap119.08M
Market cap119.08M
Price-Earnings ratio-0.11
Price-Earnings ratio-0.11
Dividend yield—
Dividend yield—
Average volume3.31M
Average volume3.31M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.13
52 Week high$2.13
52 Week low$0.035
52 Week low$0.035
People also own
Based on the portfolios of people who own PTN. This list is generated using Robinhood data, and it’s not a recommendation.